SRTA (SRTA) revenue breakdown

· Market cap $393M

By segment, Logistics is the largest at 90% of fiscal 2025 revenue.

By product, MediMobility Organ Transport and Jet is the largest at 52% of fiscal 2021 revenue, growing 128% a year over 2 years.

Revenue by segment

Fiscal years, as SRTA reports them in its 10-K filings; fiscal 2025 total $197M.

Segments20212022202320242025Share
Logistics————$177M 90%
Clinical————$20M 10%
Medical$6M$72M$127M$147M— —
Passenger$44M$74M$99M$102M— —

Revenue by product

Fiscal years, as SRTA reports them in its 10-K filings; fiscal 2021 total $51M.

Products201920202021Share
MediMobility Organ Transport and Jet$5M$13M$26M 52%
Short Distance$26M$9M$22M 44%
Other$85,000$492,000$2M 4%

Revenue by region

Fiscal years, as SRTA reports them in its 10-K filings; fiscal 2024 total $249M.

Regions202220232024Share
United States$133M$191M$219M 88%
Other$13M$34M$30M 12%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SRTA.
Open SRTA in Investingly

Questions

Where does SRTA make its money?

In fiscal 2025, by segment: Logistics $177M, Clinical $20M.

From SRTA's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.